ReviewPLoS pathogens2026
Expanding the LuxR-type receptor functional repertoire: Protein-protein interactions in quorum sensing regulation.
Review in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Essential Oils of Lamiaceae Species as Promising Sources of Antimycobacterial Agents: Current Insights, Challenges, and Future Perspectives.Molecules (Basel, Switzerland) · 2026Review
- A Nutrient-Responsive LuxR Regulator Orchestrates Effector Gene Expression Across the Legionella Genus.Molecular microbiology · 2026Article
- The conserved coordination of acyl-homoserine lactone and PqsE signaling defines the RhlR-dependent quorum-sensing network inbioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quorum sensing (QS) enables bacteria to coordinate gene expression in response to population density, with LuxR-type transcription factors playing a central role in this process for many Gram-negative species. Traditionally understood as ligand-activated transcriptional regulators, LuxR-type proteins are increasingly recognized as targets of diverse protein-protein interactions (PPIs) that modulate their activity, stability, and specificity. This review synthesizes emerging insights into the regulatory landscape of LuxR-type receptors, focusing on direct PPIs that expand the functional repertoire of LuxR-type receptors. We classify LuxR-interacting partners into negative regulators, dual or context-dependent regulators, and global regulators, highlighting the well-characterized system of PqsE-RhlR in Pseudomonas aeruginosa as well as emerging candidates. We discuss how these interactions influence LuxR-type receptor outputs beyond canonical ligand-mediated gene regulation, through stabilization of active conformations, inhibition of dimerization, proteolytic regulation, and potential recruitment of transcriptional machinery. By examining functional parallels, structural determinants, and environmental integration, we highlight a framework in which LuxR-type receptors are subject to diverse regulatory PPI that allow for the fine-tuning of QS output. Understanding these regulatory mechanisms offers promising alternatives to conventional QS disruption strategies, for targeted interference with bacterial virulence and communication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.